NYSE:GSK

GSK Wins Paxil Trademark Fight in India, But Its Bigger Test Is Still Ahead

GSK Wins Paxil Trademark Fight in India, But Its Bigger Test Is Still Ahead

The Bombay High Court ordered Shreya Life Sciences to remove its registration of the Paxil trademark, siding with Glaxo Group Limited, part of GSK. The court found Shreya had not used the mark since registering it in 2005. GSK’s ADRs fell 1.2% to $51.01 in early New York trading. Investors remain focused on GSK’s vaccine and HIV businesses rather than the trademark ruling.
May 4, 2026

Stock Market Today

  • FTSE 100: UK Retail Sector Stabilizes Amid Consumer Caution
    May 26, 2026, 7:19 AM EDT. The UK retail sector within the FTSE 100 index is showing signs of stability despite ongoing consumer caution. Market observers note a tempered growth pattern as shoppers adjust spending habits, reflecting concerns over inflation and economic uncertainty. Analysts emphasize cautious optimism, highlighting steady demand for essential goods and resilience in key retail stocks. This stabilization offers a counterbalance in the broader market, which has experienced volatility amid shifting economic conditions.